Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Charles Flexner, MD
Johns Hopkins University Hospital
Study Chair - Daniel Kuritzkes, MD
Harvard Medical School, Partners AIDS Research Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Care Center Crs
Los Angeles, California, United States
- Stanford Aids Clinical Trials Unit Crs
Palo Alto, California, United States
- Ucsd Antiviral Research Center Crs
San Diego, California, United States
- Ucsf Hiv/aids Crs
San Francisco, California, United States
- Santa Clara Valley Med. Ctr.
San Jose, California, United States
- University of Colorado Hospital Crs
Aurora, Colorado, United States
- Georgetown University Crs (gu Crs)
Washington D.C., District of Columbia, United States
- the Ponce de Leon Center Crs
Atlanta, Georgia, United States
- Rush University Crs
Chicago, Illinois, United States
- Indiana Univ. School of Medicine, Infectious Disease Research Clinic
Indianapolis, Indiana, United States
- Bmc Actg Crs
Boston, Massachusetts, United States
- Brigham and Women'S Hospital Therapeutics Clinical Research Site (bwh Tcrs) Crs
Boston, Massachusetts, United States
- Massachusetts General Hospital Crs (mgh Crs)
Boston, Massachusetts, United States
- Washington University Therapeutics (wt) Crs
St Louis, Missouri, United States
- Beth Israel Med. Ctr., Actu
New York, New York, United States
- Ny Univ. Hiv/aids Crs
New York, New York, United States
- Weill Cornell Chelsea Crs
New York, New York, United States
- Weill Cornell Uptown Crs
New York, New York, United States
- Trillium Health Actg Crs
Rochester, New York, United States
- Univ. of Rochester Actg Crs
Rochester, New York, United States
- Chapel Hill Crs
Chapel Hill, North Carolina, United States
- Case Crs
Cleveland, Ohio, United States
- Metrohealth Crs
Cleveland, Ohio, United States
- Ohio State University Crs
Columbus, Ohio, United States
- Penn Therapeutics, Crs
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Crs
Pittsburgh, Pennsylvania, United States
- the Miriam Hospital Clinical Research Site (tmh Crs) Crs
Providence, Rhode Island, United States
- Vanderbilt Therapeutics (vt) Crs
Nashville, Tennessee, United States
- Univ. of Texas Medical Branch, Actu
Galveston, Texas, United States
- University of Washington Aids Crs
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2004
- Primary completion
- 31 Dec 2005
- Completion
- 31 Jan 2011
- Last update posted
- 1 Nov 2021
- Registered enrollment
- 119
- Registry id
- NCT00082498
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.